1 – 20 of 41
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Glycemic control and outcome after carotid intervention in patients with T2D : A Swedish nationwide cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Current and future costs of obesity in Sweden
(
- Contribution to journal › Article
-
Mark
Registry-based randomised clinical trials : a remedy for evidence-based diabetes care?
(
- Contribution to journal › Scientific review
-
Mark
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
(
- Contribution to journal › Article
- 2021
-
Mark
Diabetes mellitus was not associated with lower amputation-free survival after open revascularization for chronic limb-threatening ischemia : A nationwide propensity score adjusted analysis
(
- Contribution to journal › Article
-
Mark
Higher long-term cardiovascular morbidity after open surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes - A nationwide observational cohort study
(
- Contribution to journal › Article
-
Mark
The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis
(
- Contribution to journal › Article
-
Mark
Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention : a Swedish nationwide propensity score matched cohort study
(
- Contribution to journal › Article
-
Mark
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
(
- Contribution to journal › Article
-
Mark
Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes : the PROLONG study
(
- Contribution to journal › Article
- 2020
-
Mark
Nationwide comparison of long-term survival and cardiovascular morbidity after acute aortic aneurysm repair in patients with and without type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes
(
- Contribution to journal › Article
-
Mark
Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms
(
- Contribution to journal › Article
-
Mark
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes
(
- Contribution to journal › Article
- 2019
-
Mark
Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes : A population-based and propensity-matched cohort from the Swedish National Diabetes Register
(
- Contribution to journal › Article
-
Mark
Long-term Survival and Cardiovascular Morbidity after Elective Open Aortic Aneurysm Repair in Patients with and without Type 2 Diabetes : A Nationwide Propensity-Adjusted Analysis
(
- Contribution to journal › Article
-
Mark
Survival, cardiovascular morbidity, and reinterventions after elective endovascular aortic aneurysm repair in patients with and without diabetes : A nationwide propensity-adjusted analysis
(
- Contribution to journal › Article
- 2018
-
Mark
Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus : A Nationwide Observational Study
(
- Contribution to journal › Article
- 2015
-
Mark
Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
(
- Contribution to journal › Article
-
Mark
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study.
(
- Contribution to journal › Article